SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCONI, Peggy Carla Raffaella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.516
AS - Asia 5.943
EU - Europa 3.388
SA - Sud America 978
AF - Africa 139
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.279
SG - Singapore 2.254
CN - Cina 1.440
BR - Brasile 743
IT - Italia 681
VN - Vietnam 665
UA - Ucraina 542
HK - Hong Kong 513
GB - Regno Unito 460
DE - Germania 420
PL - Polonia 351
TR - Turchia 342
FR - Francia 222
FI - Finlandia 193
JP - Giappone 184
RU - Federazione Russa 147
IN - India 114
CA - Canada 102
MX - Messico 101
SE - Svezia 97
AR - Argentina 92
ID - Indonesia 88
BD - Bangladesh 85
NL - Olanda 73
ZA - Sudafrica 61
IQ - Iraq 46
ES - Italia 40
PK - Pakistan 40
CO - Colombia 39
BE - Belgio 30
EC - Ecuador 29
AT - Austria 28
UZ - Uzbekistan 27
LT - Lituania 21
CL - Cile 20
VE - Venezuela 20
MA - Marocco 18
SA - Arabia Saudita 18
PY - Paraguay 17
IE - Irlanda 16
MY - Malesia 16
PH - Filippine 16
AE - Emirati Arabi Uniti 15
CZ - Repubblica Ceca 14
AU - Australia 13
NP - Nepal 11
CH - Svizzera 10
UY - Uruguay 10
ET - Etiopia 9
JM - Giamaica 9
PA - Panama 9
AL - Albania 7
DZ - Algeria 7
EG - Egitto 7
IL - Israele 7
IR - Iran 7
KE - Kenya 7
TN - Tunisia 7
AZ - Azerbaigian 6
CR - Costa Rica 6
JO - Giordania 6
PT - Portogallo 6
GE - Georgia 5
KR - Corea 5
NO - Norvegia 5
OM - Oman 5
BO - Bolivia 4
LB - Libano 4
TH - Thailandia 4
KW - Kuwait 3
KZ - Kazakistan 3
MZ - Mozambico 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TW - Taiwan 3
AO - Angola 2
BY - Bielorussia 2
CG - Congo 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
GH - Ghana 2
GT - Guatemala 2
HR - Croazia 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
NI - Nicaragua 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 21.961
Salva come PNG Salva come JPEG
Città #
Singapore 1.489
Ashburn 1.465
Fairfield 1.049
Woodbridge 1.034
San Jose 664
Houston 612
Jacksonville 560
Hong Kong 501
Chandler 498
Santa Clara 479
Beijing 471
Ann Arbor 437
Seattle 418
Wilmington 362
Warsaw 338
Cambridge 337
New York 323
Ferrara 218
Ho Chi Minh City 211
Dallas 193
Izmir 188
Los Angeles 184
Tokyo 172
Hanoi 165
Nanjing 149
Princeton 135
Lauterbourg 133
San Diego 108
Munich 104
São Paulo 88
Council Bluffs 82
Shanghai 67
Mexico City 61
Milan 60
Jakarta 59
Tianjin 55
Boardman 53
Shenyang 53
Bologna 49
Buffalo 49
Chicago 48
Orem 45
Helsinki 43
London 41
Montreal 41
The Dalles 40
Brooklyn 39
Turku 39
Hebei 37
Hefei 36
Poplar 35
Jiaxing 34
Chennai 33
Da Nang 33
Nanchang 32
Johannesburg 31
Frankfurt am Main 30
Brussels 29
Stockholm 29
Atlanta 28
Changsha 28
Moscow 27
San Francisco 26
Rome 25
Boston 24
Phoenix 24
Toronto 24
Manchester 23
Falls Church 22
Haiphong 22
Tashkent 22
Denver 21
Norwalk 19
Rio de Janeiro 19
Vienna 19
Amsterdam 18
Falkenstein 18
Guangzhou 18
Mountain View 18
Washington 18
Baghdad 17
Brasília 16
Dublin 16
Ningbo 16
Redwood City 16
New Delhi 15
San Mateo 15
Ankara 14
Dong Ket 14
Jinan 14
Lahore 14
Nuremberg 14
Zhengzhou 14
Auburn Hills 13
Kunming 13
Medellín 13
Orange 13
Belo Horizonte 12
Brno 12
Des Moines 12
Totale 15.114
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 315
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 269
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 266
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 265
CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis 262
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 257
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 255
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 243
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 237
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 233
Recombinant herpes simplex virus and uses therefor 226
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 223
HSV as a vector in vaccine development and gene therapy 210
Botulinum neurotoxin light chains expressed by defective herpes simplex virus type-1 vectors cleave snare proteins and inhibit cgrp release in rat sensory neurons 203
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 199
Control of Erwinia amylovora Growth by Moringa oleifera Leaf Extracts: In Vitro and in Planta Effects 199
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 198
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 197
Herpesvirus-based vaccines 196
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 194
Capitolo 55 Retrovirus 191
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice 191
HSV as a vector in vaccine development and gene therapy 190
Sustainable vs. Conventional Cleaning in Healthcare: Microbiological and Life Cycle Insights 189
Development and application of replication-incompetent HSV-1-based vectors 186
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 186
HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma 184
Herpes Simplex Virus Growth, Preparation, and Assay 184
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 182
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 181
Temporal lobe epilepsy model, neural stem cells and gene therapy 181
null 179
Herpetic vectors inhibiting angiogenesis and Inducing cell suicide in gliomas 174
Purinergic Signaling: A New Pharmacological Target Against Viruses? 173
Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8(+) T cell tolerance in vivo 171
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 171
Ethosomal Gel for Topical Administration of Dimethyl Fumarate in the Treatment of HSV-1 Infections 170
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 169
Effects of Moringa oleifera Leaf Extracts on Xanthomonas campestris pv. campestris 169
Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment 168
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 168
Herpes simplex virus type 1 infects enteric neurons and triggers gut dysfunction via macrophage recruitment 166
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 165
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 165
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 164
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice 163
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 162
Construction of Replication Defective Herpes Simplex Virus Vectors. 161
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 161
Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications 160
Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis 160
Development of Replication-Defective Herpes Simplex Virus Vectors 160
Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy 159
Herpes Simplex Virus Type 1-Derived Recombinant and Amplicon Vectors 158
Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis 157
Peripheral T Cells Re-Enter the Thymus and Interfere with Central Tolerance Induction 157
An Evaluation of Hospital Cleaning Regimes—Microbiological Evaluation and LCA Analysis after Traditional and Sustainable/Green Procedures 156
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 155
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity 155
Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach 155
Gene transfer to muscle using herpes simplex virus-based vectors 155
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 154
Connexin 43-enhanced suicide gene therapy using herpesviral vectors 153
Modulation of mucosal and systemic immunity by enteric administration of nonreplicating herpes simplex virus expressing cytokines 153
Suppressing gain-of-function proteins via CRISPR/Cas9 system in SCA1 cells 153
Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance 152
Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo 152
Engineering herpes simplex virus vectors for CNS applications 150
MHC class I cross-presentation by dendritic cells counteracts viral immune evasion 150
Capitolo 44 Herpesviridae 150
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties 149
Analysis of Civil Environments Cleaning Services—Microbiological and LCA Analysis after Traditional and Sustainable Procedures 148
Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system 148
Cytokine gene delivery into the central nervous system using intrathecally injected nonreplicative viral vectors 147
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis 147
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model 146
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 145
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 145
Generation of a human induced pluripotent stem cell line (UNIFEi001-A) from a patient with Spinocerebellar ataxia type 1 (SCA1) 142
Herpes Simplex Virus ICP27 Protein Inhibits AIM 2-Dependent Inflammasome Influencing Pro-Inflammatory Cytokines Release in Human Pigment Epithelial Cells (hTert-RPE 1) 142
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG35-55-induced experimental autoimmune encephalomyelitis in C57BL/6 mice 142
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons 142
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 142
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 140
Comunicazione orale, Keynote speaker: Herpes Simplex Vector Expressing Hiv1 Tat: A New Strategy For Vaccine Development 140
Cytokine gene therapy of autoimmune demyelination revisited using herpes simplex virus type-1-derived vectors 139
Natural Polyphenol-Containing Gels against HSV-1 Infection: A Comparative Study 139
Magnolia officinalis L. bark extract and respiratory diseases: From traditional Chinese medicine to western medicine via network target 136
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 136
Rapid method for construction of recombinant HSV gene transfer vectors 135
Replication-defective herpes simplex virus vectors for gene transfer in vivo 134
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vector 134
Gene transfer to muscle and spinal cord using herpes simplex virus-based vectors. 134
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 133
Implications of maturation for viral gene delivery to skeletal muscle 132
Chapter 8: Gene-transfer Tool: Herpes Simplex Virus Vectors 132
Evaluating Cleaning Services in Civil Environments: Microbiological and Life Cycle Analysis Comparing Conventional and Sustainable Methods 130
Chapter 7 Gene Transfer to Muscle and Spinal Cord Using Herpes Simplex Virus-Based Vectors 129
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 129
Construction of replication-defective herpes simplex virus vectors. 128
Totale 17.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 14.721
Totale 111.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021520 0 0 0 0 0 0 0 0 0 240 180 100
2021/20221.383 48 182 75 63 53 48 94 80 61 103 134 442
2022/20231.200 147 29 63 136 159 181 47 140 172 21 73 32
2023/2024890 80 85 42 26 39 264 55 43 21 25 22 188
2024/20252.886 82 80 235 112 385 317 47 172 380 332 426 318
2025/20268.652 962 347 817 1.178 1.262 623 1.024 514 979 946 0 0
Totale 22.210